NCT03755141 2025-07-22
Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer
National Cancer Center, Korea
Phase 2 Completed
National Cancer Center, Korea
National Institute of Cancerología
Turku University Hospital
Centro de Investigación en. Enfermedades Infecciosas, Mexico